In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti-factor VIII Immune Responses in Hemophilia A Mice Treated With Factor VIII Plasmid-mediated Gene Therapy-Reference-Cited by-同舟云学术

In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti-factor VIII Immune Responses in Hemophilia A Mice Treated With Factor VIII Plasmid-mediated Gene Therapy

Published:2011-08 Issue:8 Volume:19 Page:1511-1520
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Liu Chao-Lien,Ye Peiqing,Yen Benjamin C,Miao Carol H

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Molecular genetics of hemophilia A in man (factor VIII deficiency);Antonarakis;Mol Biol Med,1987

2. Factor VIII inhibitors: risk factors and methods for prevention and immune modulation;Zhang;Clin Rev Allergy Immunol,2009

3. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice;VandenDriessche;Proc Natl Acad Sci USA,1999

4. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion;Powell;Blood,2003

5. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice;Ye;Mol Ther,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of FoxP3⁺ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy;Human Gene Therapy;2024-07-01

2. Multiomics in autoimmune diseases;Biological Insights of Multi-Omics Technologies in Human Diseases;2024

3. Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy;Molecular Therapy - Nucleic Acids;2023-12

4. Altered frequency of FOXP3⁺ regulatory T cells is associated with development of inhibitors in patients with severe hemophilia A;International Journal of Laboratory Hematology;2023-07-24

5. Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice;Cellular Immunology;2023-03